Table of Content


Introduction
Tyrosine Protein Kise SYK (Spleen Tyrosine Kise or p72 Syk or SYK or EC 2.7.10.2) - Overview
Tyrosine Protein Kise SYK (Spleen Tyrosine Kise or p72 Syk or SYK or EC 2.7.10.2) - Therapeutics Development
Tyrosine Protein Kise SYK (Spleen Tyrosine Kise or p72 Syk or SYK or EC 2.7.10.2) - Therapeutics Assessment
Tyrosine Protein Kise SYK (Spleen Tyrosine Kise or p72 Syk or SYK or EC 2.7.10.2) - Companies Involved in Therapeutics Development
Tyrosine Protein Kise SYK (Spleen Tyrosine Kise or p72 Syk or SYK or EC 2.7.10.2) - Drug Profiles
Tyrosine Protein Kise SYK (Spleen Tyrosine Kise or p72 Syk or SYK or EC 2.7.10.2) - Dormant Products
Tyrosine Protein Kise SYK (Spleen Tyrosine Kise or p72 Syk or SYK or EC 2.7.10.2) - Discontinued Products
Tyrosine Protein Kise SYK (Spleen Tyrosine Kise or p72 Syk or SYK or EC 2.7.10.2) - Product Development Milestones
Appendix



List of Figures


Number of Products under Development by Stage of Development, 2021
Number of Products under Development by Therapy Areas, 2021
Number of Products under Development by Top 10 Indications, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Type, 2021


List of Tables


Number of Products under Development by Stage of Development, 2021
Number of Products under Development by Therapy Areas, 2021
Number of Products under Development by Indications, 2021
Number of Products under Development by Indications, 2021 (Contd..1)
Number of Products under Development by Indications, 2021 (Contd..2)
Number of Products under Development by Companies, 2021
Number of Products under Development by Companies, 2021 (Contd..1)
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Products under Development by Companies, 2021 (Contd..2)
Products under Development by Companies, 2021 (Contd..3)
Products under Development by Companies, 2021 (Contd..4)
Products under Development by Companies, 2021 (Contd..5)
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Pipeline by AB Science SA, 2021
Pipeline by Alexion Pharmaceuticals Inc, 2021
Pipeline by Archer Pharmaceuticals Inc, 2021
Pipeline by Asana BioSciences LLC, 2021
Pipeline by Beijing Hanmi Pharmaceutical Co Ltd, 2021
Pipeline by Clevexel Pharma SA, 2021
Pipeline by Genosco Inc, 2021
Pipeline by GlaxoSmithKline Plc, 2021
Pipeline by Hanmi Pharmaceuticals Co Ltd, 2021
Pipeline by Hutchison MediPharma Ltd, 2021
Pipeline by IACTA Pharmaceuticals Inc, 2021
Pipeline by Japan Tobacco Inc, 2021
Pipeline by Kronos Bio Inc, 2021
Pipeline by Levolta Pharmaceuticals Inc, 2021
Pipeline by Millennium Pharmaceuticals Inc, 2021
Pipeline by Nano Biotherapeutics Inc, 2021
Pipeline by Origenis GmbH, 2021
Pipeline by Pulmatrix Inc, 2021
Pipeline by Rigel Pharmaceuticals Inc, 2021
Pipeline by Taiho Pharmaceutical Co Ltd, 2021
Pipeline by TopiVert Ltd, 2021
Dormant Products, 2021
Dormant Products, 2021 (Contd..1)
Dormant Products, 2021 (Contd..2)
Dormant Products, 2021 (Contd..3)
Dormant Products, 2021 (Contd..4)
Dormant Products, 2021 (Contd..5)
Discontinued Products, 2021
Discontinued Products, 2021 (Contd..1)